EE24 The Cost-Effectiveness of Atidarsagene Autotemcel for the Treatment of Metachromatic Leukodystrophy (MLD) in France
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.276
https://www.valueinhealthjournal.com/article/S1098-3015(22)00477-6/fulltext
Title :
EE24 The Cost-Effectiveness of Atidarsagene Autotemcel for the Treatment of Metachromatic Leukodystrophy (MLD) in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00477-6&doi=10.1016/j.jval.2022.04.276
First page :
Section Title :
Open access? :
No
Section Order :
10239